Correlation Between Molecular Templates and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Royalty Pharma Plc, you can compare the effects of market volatilities on Molecular Templates and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Royalty Pharma.
Diversification Opportunities for Molecular Templates and Royalty Pharma
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Molecular and Royalty is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Molecular Templates i.e., Molecular Templates and Royalty Pharma go up and down completely randomly.
Pair Corralation between Molecular Templates and Royalty Pharma
Given the investment horizon of 90 days Molecular Templates is expected to generate 20.21 times more return on investment than Royalty Pharma. However, Molecular Templates is 20.21 times more volatile than Royalty Pharma Plc. It trades about 0.03 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.05 per unit of risk. If you would invest 45.00 in Molecular Templates on August 31, 2024 and sell it today you would lose (8.00) from holding Molecular Templates or give up 17.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Royalty Pharma Plc
Performance |
| Timeline |
| Molecular Templates |
| Royalty Pharma Plc |
Molecular Templates and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Royalty Pharma
The main advantage of trading using opposite Molecular Templates and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Molecular Templates vs. Century Therapeutics | Molecular Templates vs. Kezar Life Sciences | Molecular Templates vs. Mineralys Therapeutics, Common | Molecular Templates vs. Nkarta Inc |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |